Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
mistake (35)
,
fault (22)
,
slip (31)
Thyroid Cabozantinib
Description
Chemotherapy Protocol THYROID CANCER Regimen CABOZANTINIB • Thyroid – Cabozantinib (140mg-capsules) Indication • Unresectable, locally advanced or metastatic thyroid cancer where the disease
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Thyroid-Cabozantinib.pdf
Lenvatinib
Description
Chemotherapy Protocol THYROID CANCER LENVATINIB Regimen • Thyroid – Lenvatinib Indication • The treatment of differentiated thyroid cancer after radioactive iodine where all the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Lenvatinib.pdf
Capecitabine-Streptozocin
Description
Chemotherapy Protocol NEUROENDOCRINE CAPECITABINE-STREPTOZOCIN Regimen • Neuroendocrine – Capecitabine-Streptozocin Indication • Metastatic or locally advance neuroendocrine tumours irrespective of primary site, predominantly
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Capecitabine-Streptozocin.pdf
Atezolizumab-Paclitaxel Albumin Bound
Description
Chemotherapy Protocol BREAST CANCER Atezolizumab-Paclitaxel Albumin Bound Regimen • Breast – Atezolizumab-Paclitaxel Albumin Bound Indication • Atezolizumab in combination with paclitaxel albumin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Atezolizumab-Paclitaxel-Albumin-Bound.pdf
Anastrozole-Ribociclib
Description
Chemotherapy Protocol Breast Cancer Anastrozole-Ribociclib Regimen • Breast Cancer – Anastrozole-Ribociclib Indication • Ribociclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Anastrozole-Ribociclib.pdf
Abemaciclib-Fulvestrant
Description
Chemotherapy Protocol Breast Cancer Abemaciclib-Fulvestrant Regimen • Breast Cancer – Abemaciclib-Fulvestrant Indication • Abemaciclib in combination with fulvestrant is indicated for the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Fulvestrant.pdf
Abemaciclib-Anastrozole
Description
Chemotherapy Protocol Breast Cancer Abemaciclib-Anastrozole Regimen • Breast Cancer – Abemaciclib-Anastrozole Indication • Abemaciclib in combination with an aromatase inhibitor is indicated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Abemaciclib-Anastrozole.pdf
Enhertu (trastuzumab deruxtecan)
Description
Chemotherapy Protocol BREAST CANCER ENHERTU (trastuzumab deruxtecan) ENHERTU is NOT the same drug as Kadcyla (trastuzumab emtansine) or generic trastuzumab). There
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Enhertu-trastuzumab-deruxtecan.pdf
SHAPE Award Guide
Description
SHAPE FUNDING AWARDS Southampton Academy of Research (SoAR) in collaboration with Applied Research Collaboration (ARC Wessex) 1. Internship Awards 2. Transitional/ Bridging Awards 3. Post Doctoral Awards Year 2020/ 2021 Contents Introduction:........................................................................................................................................... 2 Internship Award...................................................................................................
Url
/Media/Southampton-Clinical-Research/Downloads/SHAPE-Award-Guide.pdf
NIHR expression of interest
Description
NIHR CRN Site Identification Support Expression of Interest (EOI) Guidance (v2 May 2018) The expression of interest process is intended to
Url
/Media/Southampton-Clinical-Research/NIHR-expression-of-interest.pdf
571
to
580
of
630
Previous
…
56
57
58
59
60
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.